Fractora Dry is designed for patients with excessive sweating called hyperhydrosis – a condition characterized by abnormally increased perspiration in excess of that required for the normal regulation of body temperature. This condition affects 2.8% of Americans, some 7.8 million people, and half of these suffer from axillary hyperhidrosis. Botox® will help dry up these hyperactive sweat glands but very large quantities (100 units per side) and frequent injections are required to control this condition with Botox®. Fractora Dry combines radiofrequency with microneedling technology to treat this condition equally effectively by heating the subdermal glands and knocking out their function.

Price includes 2 in-office treatments. Some swelling and soreness is expected during the following week, which will resolve uneventfully.